Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Phenyramidol HCl vs Cabral in Healthy Males
NCT04639869Phase 1Completed
- Sponsor
- Humanis
- Start
- Jun 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fenyramidol in Muscle spasm (4 arms), sponsored by Humanis. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve to Last Timepoint and 1 more. Started Jun 2019; status: completed.
02
Drugs
fenyramidol
03
Conditions
Muscle spasm
Beyond the preview
Go deeper on NCT04639869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04639869.